Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Choroidal Ischemia
NCT04356716Phase 2Completed
- Sponsor
- Columbia University
- Start
- Nov 2014
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in choroidal ischemia, vitelliform macular dystrophy, age-related macular degeneration (AMD), central serous retinopathy (CSR), retinitis pigmentosa (RP), sponsored by Columbia University. Started Nov 2014; status: completed.
02
Drugs
sildenafil
03
Conditions
choroidal ischemiavitelliform macular dystrophyage-related macular degeneration (AMD)central serous retinopathy (CSR)retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT04356716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04356716.